Vinorelbine Tartrate
Overview
Vinorelbine Tartrate is a semi-synthetic vinca alkaloid used to treat certain types of cancer, including non-small cell lung cancer. It works by inhibiting mitosis, thereby preventing the multiplication of cancer cells.
API suppliers (6)
Suppliers of Vinorelbine Tartrate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 6 suppliers.
1 holds a European CEP for this substance
- HUBEI HONCH PHARMACEUTICAL CO LTD1 active DMF
- PIERRE FABRE MEDICAMENTFrance1 active DMF
- MINAKEM HIGH POTENTBelgium1 active DMF
- MINAKEMFranceCEP
- ALP PHARM BEIJING CO LTD
- SYNBIAS PHARMA AGFrance
Therapeutic areas
Do you supply Vinorelbine Tartrate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.